Premium
New‐onset psoriasis following treatment with the interleukin‐1 receptor antagonist anakinra
Author(s) -
GonzálezLópez M.A.,
MartínezTaboada V.M.,
GonzálezVela M.C.,
FernándezLlaca H.,
ValBernal J.F.
Publication year - 2008
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2008.08470.x
Subject(s) - anakinra , medicine , adalimumab , etanercept , infliximab , psoriasis , rheumatoid arthritis , psoriatic arthritis , dermatology , adverse effect , methotrexate , discontinuation , interleukin 1 receptor antagonist , surgery , receptor antagonist , gastroenterology , immunology , tumor necrosis factor alpha , antagonist , disease , receptor